LA Times: California's Stem Cell Agency and Rising Concerns About Drug Costs
Bloomberg News describes this $1 million gene therapy
as the world's most expensive medicine
Highlights
CIRM's affordability role
Risk-reward calculations
Burden on industry and CIRM
The Los Angeles Times has a Sunday readership of 2.4 million, and tomorrow they will be seeing this headline.
“Sky-high price of new stem cell therapies is a growing concern”
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.